Search research articles
Contact Us
Filters
Showing results (61-70 of 79) with videos related to
Page
of 8
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 23, 1999
Phase I and pharmacologic study of 9-aminocamptothecin colloidal dispersion formulation in patients with refractory or relapsed acute leukemia
N Vey, H Kantarjian, H Tran, et al.
Leukemia Research
|
December 13, 2006
Soluble phosphorylated fms-like tyrosine kinase III. FLT3 protein in patients with acute myeloid leukemia (AML)
F Ravandi, I Jilani, E Estey, et al.
Clinical Pharmacology and Therapeutics
|
November 20, 2009
Clinical pharmacokinetics of the BCR-ABL tyrosine kinase inhibitor nilotinib
C Tanaka, O Q P Yin, V Sethuraman, et al.
Leukemia
|
July 6, 2007
UGT1A1 promoter polymorphism increases risk of nilotinib-induced hyperbilirubinemia
J B Singer, Y Shou, F Giles, et al.
Leukemia
|
July 21, 2006
Frequency and clinical significance of BCR-ABL mutations in patients with chronic myeloid leukemia treated with imatinib mesylate
E Jabbour, H Kantarjian, D Jones, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 1, 1997
Mitoguazone therapy in patients with refractory or relapsed AIDS-related lymphoma: results from a multicenter phase II trial
A M Levine, A Tulpule, D Tessman, et al.
Neurological Research
|
October 21, 2004
Symptomatic protocols for adult tethered cord syndrome
Shokei Yamada, Javed Siddiqi, Daniel J Won, et al.
Nucleic Acids Research
|
December 19, 2003
CADRE: the Central Aspergillus Data REpository
J E Mabey, M J Anderson, P F Giles, et al.
Leukemia
|
May 26, 2012
Phase IB study of the FLT3 kinase inhibitor midostaurin with chemotherapy in younger newly diagnosed adult patients with acute myeloid leukemia
R M Stone, T Fischer, R Paquette, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
September 24, 2008
Neanderthal exploitation of marine mammals in Gibraltar
C B Stringer, J C Finlayson, R N E Barton, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 79) with videos related to
Sort By:
Page
of 8
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 23, 1999
Phase I and pharmacologic study of 9-aminocamptothecin colloidal dispersion formulation in patients with refractory or relapsed acute leukemia
N Vey, H Kantarjian, H Tran, et al.
Leukemia Research
|
December 13, 2006
Soluble phosphorylated fms-like tyrosine kinase III. FLT3 protein in patients with acute myeloid leukemia (AML)
F Ravandi, I Jilani, E Estey, et al.
Clinical Pharmacology and Therapeutics
|
November 20, 2009
Clinical pharmacokinetics of the BCR-ABL tyrosine kinase inhibitor nilotinib
C Tanaka, O Q P Yin, V Sethuraman, et al.
Leukemia
|
July 6, 2007
UGT1A1 promoter polymorphism increases risk of nilotinib-induced hyperbilirubinemia
J B Singer, Y Shou, F Giles, et al.
Leukemia
|
July 21, 2006
Frequency and clinical significance of BCR-ABL mutations in patients with chronic myeloid leukemia treated with imatinib mesylate
E Jabbour, H Kantarjian, D Jones, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 1, 1997
Mitoguazone therapy in patients with refractory or relapsed AIDS-related lymphoma: results from a multicenter phase II trial
A M Levine, A Tulpule, D Tessman, et al.
Neurological Research
|
October 21, 2004
Symptomatic protocols for adult tethered cord syndrome
Shokei Yamada, Javed Siddiqi, Daniel J Won, et al.
Nucleic Acids Research
|
December 19, 2003
CADRE: the Central Aspergillus Data REpository
J E Mabey, M J Anderson, P F Giles, et al.
Leukemia
|
May 26, 2012
Phase IB study of the FLT3 kinase inhibitor midostaurin with chemotherapy in younger newly diagnosed adult patients with acute myeloid leukemia
R M Stone, T Fischer, R Paquette, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
September 24, 2008
Neanderthal exploitation of marine mammals in Gibraltar
C B Stringer, J C Finlayson, R N E Barton, et al.
Page
of 8